These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
600 related articles for article (PubMed ID: 15634757)
41. Molecular determinants of response to TRAIL in killing of normal and cancer cells. Kim K; Fisher MJ; Xu SQ; el-Deiry WS Clin Cancer Res; 2000 Feb; 6(2):335-46. PubMed ID: 10690508 [TBL] [Abstract][Full Text] [Related]
42. Aberrant promoter hypermethylation of the death-associated protein kinase gene is early and frequent in murine lung tumors induced by cigarette smoke and tobacco carcinogens. Pulling LC; Vuillemenot BR; Hutt JA; Devereux TR; Belinsky SA Cancer Res; 2004 Jun; 64(11):3844-8. PubMed ID: 15172992 [TBL] [Abstract][Full Text] [Related]
43. IGFBP-3 hypermethylation-derived deficiency mediates cisplatin resistance in non-small-cell lung cancer. Ibanez de Caceres I; Cortes-Sempere M; Moratilla C; Machado-Pinilla R; Rodriguez-Fanjul V; Manguán-García C; Cejas P; López-Ríos F; Paz-Ares L; de CastroCarpeño J; Nistal M; Belda-Iniesta C; Perona R Oncogene; 2010 Mar; 29(11):1681-90. PubMed ID: 20023704 [TBL] [Abstract][Full Text] [Related]
44. Reversal of methylation silencing of Apo2L/TRAIL receptor 1 (DR4) expression overcomes resistance of SK-MEL-3 and SK-MEL-28 melanoma cells to interferons (IFNs) or Apo2L/TRAIL. Bae SI; Cheriyath V; Jacobs BS; Reu FJ; Borden EC Oncogene; 2008 Jan; 27(4):490-8. PubMed ID: 17653094 [TBL] [Abstract][Full Text] [Related]
45. Development of TRAIL resistance by radiation-induced hypermethylation of DR4 CpG island in recurrent laryngeal squamous cell carcinoma. Lee JC; Lee WH; Min YJ; Cha HJ; Han MW; Chang HW; Kim SA; Choi SH; Kim SW; Kim SY Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1203-11. PubMed ID: 24661673 [TBL] [Abstract][Full Text] [Related]
46. MAPK p38 and JNK have opposing activities on TRAIL-induced apoptosis activation in NSCLC H460 cells that involves RIP1 and caspase-8 and is mediated by Mcl-1. Azijli K; Yuvaraj S; van Roosmalen I; Flach K; Giovannetti E; Peters GJ; de Jong S; Kruyt FA Apoptosis; 2013 Jul; 18(7):851-60. PubMed ID: 23456625 [TBL] [Abstract][Full Text] [Related]
47. Sensitization for death receptor- or drug-induced apoptosis by re-expression of caspase-8 through demethylation or gene transfer. Fulda S; Küfer MU; Meyer E; van Valen F; Dockhorn-Dworniczak B; Debatin KM Oncogene; 2001 Sep; 20(41):5865-77. PubMed ID: 11593392 [TBL] [Abstract][Full Text] [Related]
48. 5-Aza-CdR can reverse gefitinib resistance caused by DAPK gene promoter methylation in lung adenocarcinoma cells. Yang B; Yang ZG; Gao B; Shao GG; Li GH Int J Clin Exp Pathol; 2015; 8(10):12961-6. PubMed ID: 26722491 [TBL] [Abstract][Full Text] [Related]
49. Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAIL. Johnsen JI; Pettersen I; Ponthan F; Sveinbjørnsson B; Flaegstad T; Kogner P Int J Oncol; 2004 Dec; 25(6):1849-57. PubMed ID: 15547726 [TBL] [Abstract][Full Text] [Related]
50. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin. Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094 [TBL] [Abstract][Full Text] [Related]
51. Effect of methylation-associated silencing of the death-associated protein kinase gene on nasopharyngeal carcinoma. Kong WJ; Zhang S; Guo CK; Wang YJ; Chen X; Zhang SL; Zhang D; Liu Z; Kong W Anticancer Drugs; 2006 Mar; 17(3):251-9. PubMed ID: 16520653 [TBL] [Abstract][Full Text] [Related]
52. TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention. Ahmad M; Shi Y Oncogene; 2000 Jul; 19(30):3363-71. PubMed ID: 10918593 [TBL] [Abstract][Full Text] [Related]
53. Resistance and susceptibility of human uveal melanoma cells to TRAIL-induced apoptosis. Li H; Niederkorn JY; Neelam S; Alizadeh H Arch Ophthalmol; 2005 May; 123(5):654-61. PubMed ID: 15883285 [TBL] [Abstract][Full Text] [Related]
54. Cisplatin-dependent upregulation of death receptors 4 and 5 augments induction of apoptosis by TNF-related apoptosis-inducing ligand against esophageal squamous cell carcinoma. Kondo K; Yamasaki S; Sugie T; Teratani N; Kan T; Imamura M; Shimada Y Int J Cancer; 2006 Jan; 118(1):230-42. PubMed ID: 16003725 [TBL] [Abstract][Full Text] [Related]
56. Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex. Izeradjene K; Douglas L; Delaney AB; Houghton JA Cancer Res; 2004 Nov; 64(21):8036-44. PubMed ID: 15520213 [TBL] [Abstract][Full Text] [Related]